Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The first IPO in more than three years probably won’t reignite the Portuguese market -
Like Renk and Douglas, Galderma has turned to the loan market over bonds after floating
-
The biggest IPO of 2024 so far in Europe has delivered a welcome bounce in the aftermarket
-
Galderma will provide the European IPO market with another important data point when it begins trading on Friday
-
The final size of the base deal will be Sfr2bn after the IPO was priced at the top of the range
-
The biggest IPO of the year so far in Europe is multiple times covered, according to sources
